|
Market Closed -
NYSE
20:00:03 28/10/2026 GMT
|
Pre-market 12:08:17 | |||
| 20.15 USD | -0.59% |
|
20.50 | +1.74% |
| 11:52am | Takeda Pharmaceutical Company Limited, Q2 2027 Earnings Call, Oct 29, 2026 | |
| 10:28am | Takeda Pharmaceutical Posts Higher H1 Attributable Net Profit; Revenue Up | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.50% | +1.38% | +8.74% | +5.54% | +19.88% | +57.09% | +129.96% | +408.51% | +1,628.57% | 1,148B | ||
| +0.86% | +5.14% | -0.33% | +1.62% | +30.97% | +45.00% | +86.15% | +66.44% | +135.01% | 652B | ||
| -0.14% | +0.42% | +7.40% | +8.66% | +25.17% | +25.69% | +105.85% | +160.77% | +396.51% | 505B | ||
| +0.63% | +2.04% | +14.54% | +10.62% | +21.91% | +53.65% | +65.81% | +13.01% | +75.87% | 384B | ||
| -0.63% | -5.97% | -5.22% | +6.91% | +33.89% | +61.93% | +37.06% | +62.83% | +139.51% | 348B | ||
| +3.50% | +3.06% | +9.84% | +2.37% | +21.19% | +34.84% | +56.94% | +75.59% | +88.66% | 294B | ||
| +1.96% | -0.08% | +4.36% | -1.25% | -5.95% | +3.26% | +26.93% | +42.62% | +182.69% | 264B | ||
| +0.87% | +3.08% | +8.06% | +14.94% | +38.04% | +54.69% | +72.74% | +118.10% | +211.22% | 244B | ||
| +0.08% | +3.67% | +4.59% | +18.52% | +29.71% | +35.05% | +107.78% | +136.41% | +115.48% | 197B | ||
| +1.18% | -3.21% | +1.83% | -24.20% | -21.21% | -23.47% | -62.19% | -27.23% | +111.43% | 168B | ||
| -1.17% | -1.34% | +2.54% | +16.63% | +18.27% | +20.20% | -2.19% | -31.80% | -7.77% | 168B | ||
| +1.66% | +0.99% | +0.38% | +8.01% | +16.84% | +25.40% | +49.09% | +191.04% | +582.77% | 134B | ||
| -1.59% | -0.90% | -5.18% | -4.76% | +12.29% | +41.45% | +18.72% | +6.02% | +18.76% | 124B | ||
| -0.67% | -5.41% | +12.18% | +7.99% | +17.10% | +19.39% | +114.40% | +368.52% | +673.96% | 112B | ||
| -1.08% | -5.69% | -2.75% | -10.06% | -1.07% | +3.03% | +24.28% | -4.28% | -10.78% | 97.74B | ||
| +0.99% | +1.73% | +6.69% | -4.59% | -7.82% | -13.27% | -9.38% | -11.78% | +7.45% | 101B | ||
| +2.98% | -12.87% | +8.56% | +283.77% | +626.23% | +744.83% | +197.82% | -38.44% | - | 85.5B | ||
| -0.35% | +0.94% | +8.11% | +16.99% | +5.36% | +24.26% | +4.91% | +30.08% | +128.56% | 81.21B | ||
| +2.98% | +2.15% | +8.81% | +3.03% | +21.94% | +30.06% | +8.45% | -26.79% | +59.62% | 70.77B | ||
| Average | +1.74% | -0.28% | +4.90% | +18.99% | +47.51% | +65.43% | +54.38% | +81.03% | +252.09% | 272.59B | |
| Weighted average by Cap. | +2.19% | +0.79% | +5.44% | +9.74% | +30.04% | +49.87% | +75.34% | +147.35% | +505.07% |
- Stock Market
- Stocks
- 4502 Stock
- TAK Stock
- Sector Takeda Pharmaceutical Company Limited
Select your edition
All financial news and data tailored to specific country editions
















